Childhood interstitial lung disease (chILD) encompasses a diverse group of genetic, infectious, and inflammatory conditions affecting infants and children. The recognition and …
EM DeBoer, DR Liptzin, SM Humphries… - Pediatric …, 2021 - Wiley Online Library
Introduction Therapeutics exist to treat fibrotic lung disease in adults, but these have not been investigated in children. Defining biomarkers for pediatric fibrotic lung disease in …
Interstitial and diffuse lung diseases in children constitute a range of congenital and acquired disorders. These disorders present with signs and symptoms of respiratory disease …
DR Liptzin, CD Baker, JR Darst… - Pediatric …, 2018 - Wiley Online Library
Objectives We sought to describe the phenotype for patients with PIG including presentation, evaluation, cardiac co‐morbidities, high resolution computed tomography findings, and …
H Giunta-Stibb, B Hackett - Journal of Perinatology, 2025 - nature.com
Although relatively rare, interstitial lung diseases may present with respiratory distress in the newborn period. Most commonly these include developmental and growth disorders …
T Semple, AJ Winant, EY Lee - Radiologic Clinics, 2022 - radiologic.theclinics.com
Childhood interstitial lung disease (ChILD) is an umbrella term encompassing a diverse group of diffuse lung diseases affecting infants and children. Although the timely and …
A Casey, EK Fiorino… - Clinics in chest medicine, 2024 - chestmed.theclinics.com
Childhood interstitial and diffuse lung disease (chILD) is an umbrella term that encompasses numerous heterogeneous, diffuse lung disorders. Most chILD disorders are rare or ultra …
Background The expression of the NKX2–1 gene and its encoded protein, thyroid transcription factor 1 (TTF-1), plays a role in pulmonary surfactant homeostasis and lung …
Background Germline mutation in bone morphogenetic protein type II (BMPR2) is the most common cause of idiopathic/heritable pulmonary hypertension in pediatric patients. Despite …